AAUM (Average Assets Under Management) of ₹119.47 Cr for Apr-Jun 2026 is the combined figure across Direct and Regular plans — sourced from AMFI India's quarterly disclosure. Equity Holdings above shows only the stock portion from the latest portfolio filing.
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 99.9% | 100.0% | ● +0.0% |
| Sector | Prev | Curr ▼ | Delta |
|---|---|---|---|
| Pharmaceuticals & Biotechnology | 100.0% | 99.9% | ● 0.0% |
Comparing Jul 2026 → Aug 2026
| # | Stock | Sector | Jul 2026 | Aug 2026 | Change |
|---|---|---|---|---|---|
| 1 | Divi's Laboratories Limited ₹18.64 Cr |
Pharmaceuticals & Biotechnology | 10.36% | 11.88% | +1.52% |
| 2 | Glenmark Pharmaceuticals Limited ₹5.78 Cr |
Pharmaceuticals & Biotechnology | 3.40% | 3.69% | +0.29% |
| 3 | Aurobindo Pharma Limited ₹7.36 Cr |
Pharmaceuticals & Biotechnology | 4.43% | 4.69% | +0.26% |
| 4 | IPCA Laboratories Limited ₹4.25 Cr |
Pharmaceuticals & Biotechnology | 2.46% | 2.71% | +0.25% |
| 5 | Gland Pharma Limited ₹3.56 Cr |
Pharmaceuticals & Biotechnology | 2.02% | 2.27% | +0.25% |
| 6 | Laurus Labs Limited ₹11.55 Cr |
Pharmaceuticals & Biotechnology | 7.15% | 7.36% | +0.21% |
| 7 | Sai Life Sciences Limited ₹3.12 Cr |
Pharmaceuticals & Biotechnology | 1.84% | 1.99% | +0.15% |
| 8 | Piramal Pharma Limited ₹2.07 Cr |
Pharmaceuticals & Biotechnology | 1.23% | 1.32% | +0.09% |
| 9 | Zydus Lifesciences Limited ₹4.50 Cr |
Pharmaceuticals & Biotechnology | 2.85% | 2.87% | +0.02% |
| 10 | Ajanta Pharma Limited ₹2.35 Cr |
Pharmaceuticals & Biotechnology | 1.48% | 1.50% | +0.02% |
| # | Stock | Sector | Jul 2026 | Aug 2026 | Change |
|---|---|---|---|---|---|
| 1 | Lupin Limited ₹8.24 Cr |
Pharmaceuticals & Biotechnology | 5.94% | 5.25% | -0.69% |
| 2 | Sun Pharmaceutical Industries Limited ₹32.57 Cr |
Pharmaceuticals & Biotechnology | 21.33% | 20.76% | -0.57% |
| 3 | Cipla Limited ₹12.29 Cr |
Pharmaceuticals & Biotechnology | 8.39% | 7.83% | -0.56% |
| 4 | Alkem Laboratories Limited ₹4.83 Cr |
Pharmaceuticals & Biotechnology | 3.40% | 3.08% | -0.32% |
| 5 | Torrent Pharmaceuticals Limited ₹11.51 Cr |
Pharmaceuticals & Biotechnology | 7.60% | 7.34% | -0.26% |
| 6 | Biocon Limited ₹4.56 Cr |
Pharmaceuticals & Biotechnology | 3.07% | 2.90% | -0.17% |
| 7 | Abbott India Limited ₹2.06 Cr |
Pharmaceuticals & Biotechnology | 1.46% | 1.31% | -0.15% |
| 8 | Dr. Reddy's Laboratories Limited ₹10.91 Cr |
Pharmaceuticals & Biotechnology | 7.08% | 6.95% | -0.13% |
| 9 | Mankind Pharma Limited ₹4.24 Cr |
Pharmaceuticals & Biotechnology | 2.83% | 2.70% | -0.13% |
| 10 | Wockhardt Limited ₹2.41 Cr |
Pharmaceuticals & Biotechnology | 1.64% | 1.54% | -0.10% |
20 stocks — Aug 2026
| # | Stock | Sector | Cap | Weight & Value |
|---|---|---|---|---|
| 1 |
₹32.57 Cr |
Pharmaceuticals & Biotechnology |
20.76%
|
|
| 2 |
₹18.64 Cr |
Pharmaceuticals & Biotechnology |
11.88%
|
|
| 3 |
₹12.29 Cr |
Pharmaceuticals & Biotechnology |
7.83%
|
|
| 4 |
₹11.55 Cr |
Pharmaceuticals & Biotechnology |
7.36%
|
|
| 5 |
₹11.51 Cr |
Pharmaceuticals & Biotechnology |
7.34%
|
|
| 6 |
₹10.91 Cr |
Pharmaceuticals & Biotechnology |
6.95%
|
|
| 7 |
₹8.24 Cr |
Pharmaceuticals & Biotechnology |
5.25%
|
|
| 8 |
₹7.36 Cr |
Pharmaceuticals & Biotechnology |
4.69%
|
|
| 9 |
₹5.78 Cr |
Pharmaceuticals & Biotechnology |
3.69%
|
|
| 10 |
₹4.83 Cr |
Pharmaceuticals & Biotechnology |
3.08%
|
Disclaimer: Data sourced from individual AMC monthly portfolio disclosures, as mandated by SEBI/AMFI. While we strive for accuracy, errors in parsing or presentation may occasionally occur. This is not investment advice. Please consult a SEBI-registered investment adviser before making any investment decisions.
Found a discrepancy or have feedback? Contact Us — we read every message personally.